DECIPHER.BO · BSE

DECIPHER LABS LIMITED

₹5.5

-0.18% (-₹0.01)

Prev. close

₹5.51

Volume

936

As of

18 Sept 2026

Price history

₹5.5-₹0.73 (-11.72%) · 3M
17 Jun 202618 Sept 2026
₹7.3₹5.417 Jun10 Jul04 Aug26 Aug18 Sept
Daily closes · updates after each session

No analyst calls on this stock in the last 90 days yet.

Explore by date range →

Analyst opinions

No analyst calls on DECIPHER LABS LIMITED in the last 90 days.

Fundamentals

About DECIPHER LABS LIMITED

Decipher Labs Limited, together with its subsidiaries, manufactures, markets, sells, and trades in pharmaceutical drugs in India and internationally. It operates through two segments, Manufacturing and Trading of Pharmaceutical Drugs and Consultancy. The company offers branded and finished formulations, bulk drugs, and chemicals. It also provides information technology (IT) consultancy services comprising technology integration and systems consulting, software development consulting, and management of IT projects. In addition, the company offers ERP implementation, mobile and cloud solutions, product development, and offshore services. It serves formulators, manufacturers, and research and development agencies. The company was formerly known as Combat Drugs Limited and changed its name to Decipher Labs Limited in January 2020. Decipher Labs Limited was incorporated in 1986 and is based in Hyderabad, India.

Details

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Ms. Aruna Dalavat

Headquarters

Hyderabad

Employees

1

Key stats

Market cap

₹5.56 Cr

EPS (TTM)

₹-1.82

Beta (1Y · daily vs NIFTY 50)

1.28

Beta (5Y · monthly vs NIFTY 50)

1.75

Shares float

73.32 L

EPS · quarter ended Jun 2026

₹-2.16

Financial Performance

01 · Financials

-50 Cr0 Cr50 Cr100 Cr-100%0%100%200%FY21FY22FY23FY24FY25FY26
RevenueNet incomeEBITDARevenue growth YoY

Revenue for Mar 2021–Mar 2022 is as filed with BSE (consolidated), and the first plotted growth figure is computed against Mar 2020 revenue as filed with BSE; the two sources' revenue definitions differ by 0.0% on Mar 2023. FY21 growth needs FY20 filings, which the data source doesn't provide.

02 · Earnings Per Share (EPS)

-1001020FY21FY22FY23FY24FY25FY26

04 · Operating Efficiency (Growth Rates)

Balance-sheet-based · pre-FY23 not filed in verifiable form

-100%0%100%200%FY21FY22FY23FY24FY25FY26
SalesFixed assetsTrade receivables

05 · Capital Structure & Asset Utilization

Pre-FY23 not filed in verifiable form

0 Cr10 Cr20 Cr30 Cr40 Cr0.5×1.5×FY23FY24FY25FY26
Total assetsTotal debtDebt / equityAsset turnover

Asset turnover needs a prior year of assets — omitted for the earliest available year.

06 · Asset Base Composition

Pre-FY23 not filed in verifiable form

0 Cr10 Cr20 Cr30 Cr40 CrFY21FY22FY23FY24FY25FY26
Fixed assetsCurrent assetsOther assets

07 · Debt Level & Coverage

Pre-FY23 not filed in verifiable form

-10 Cr-5 Cr0 Cr5 Cr10 CrFY21FY22FY23FY24FY25FY26
DebtFree cash flowCash & equivalents

08 · Profit & Loss

Annual

Line itemFY21FY22FY23FY24FY25FY26
₹55.56 Cr₹65.32 Cr₹45.57 Cr₹35.88 Cr₹22.61 Cr₹14.05 Cr
EBITDA₹4.09 Cr₹13.70 Cr₹-3.30 Cr₹-54.08 L₹-6.02 Cr₹-2.70 Cr
₹1.40 Cr₹11.38 Cr₹-2.68 Cr₹-1.68 Cr₹-5.08 Cr₹-3.08 Cr
Diluted EPS₹1.39₹11.27₹-2.66₹-1.66₹-5.03₹-3.05

Depreciation & amortisation, Pretax income, Tax provision, Interest expense have filed figures for only some of the years shown — the missing years are left blank rather than estimated.

09 · Balance Sheet

Annual

Line itemFY21FY22FY23FY24FY25FY26
₹28.16 Cr₹33.63 Cr₹25.76 Cr₹24.33 Cr
₹94.94 L₹0₹24.45 L₹50.32 L
Stockholders' equity₹23.21 Cr₹21.86 Cr₹22.86 Cr₹20.67 Cr

Total assets, Current assets, Trade receivables, Cash & equivalents, Non-current assets, Fixed assets, Total debt, Long-term debt, Current (short-term) debt, Others, Stockholders' equity have filed figures for only some of the years shown — the missing years are left blank rather than estimated. Inventory shows ₹0 for 2023-03-31, 2024-03-31, 2025-03-31 — this deck's own annual-report reading has no Inventory figure for this filer in any year shown (2023-03-31, 2024-03-31, 2025-03-31, 2021-03-31, 2022-03-31 alike); the ₹0 shown here comes from this filer's own reported data feed rather than this deck's own extraction, and is positively consistent with a filer that holds no physical inventory (typical for lenders and other financial-services companies) rather than a display default. 2021-03-31, 2022-03-31 have no Inventory figure reaching this deck at all — not shown as zero, not shown as positive — left blank rather than assumed to match the other years.

Annual only — the data source doesn’t publish quarterly balance-sheet detail for most NSE-listed companies.

10 · Cash Flow Statement

Annual

Line itemFY21FY22FY23FY24FY25FY26
₹-1.56 Cr₹4.85 Cr₹-9.82 Cr₹-2.45 Cr
Investing cash flow₹-4.28 Cr₹-1.79 Cr₹3.07 Cr₹-24.09 L
Financing cash flow₹-2.15 Cr₹-1.17 Cr₹24.45 L₹-1,000
Capital expenditure₹-78.30 L₹-5.84 L₹-5.69 L₹-24.09 L
End cash position₹7.42 Cr₹9.31 Cr₹2.81 Cr₹11.96 L

Operating cash flow, Depreciation & amortization, Change in working capital, Investing cash flow, Financing cash flow, Capital expenditure, End cash position have filed figures for only some of the years shown — the missing years are left blank rather than estimated.

Annual only — the data source has no quarterly cash-flow-statement coverage.

12 · Peer Comparison

Healthcare

Company
Sun Pharmaceutical Industries Limited₹4.48 L Cr₹1,837.337.05.3613.7%0.06+11.9%+11.4%
Divi's Laboratories Limited₹2.47 L Cr₹9,37583.314.7715.3%0.00+12.3%+53.4%
Torrent Pharmaceuticals Limited₹1.83 L Cr₹4,87576.921.8225.8%1.79+21.5%+37.4%
Apollo Hospitals Enterprise Limited₹1.26 L Cr₹8,944.560.413.3020.5%0.90+15.7%+13.9%
Lenskart Solutions Limited₹1.18 L Cr₹707.2179.913.485.6%0.35+35.4%
Zydus Lifesciences Limited₹1.13 L Cr₹1,16025.34.1818.6%0.46+18.4%+10.7%
Cipla Limited₹1.10 L Cr₹1,376.332.53.1911.3%0.02+2.1%-11.8%
Laurus Labs Limited₹1.05 L Cr₹1,95496.419.8616.8%0.48+22.0%+111.6%
Max Healthcare Institute Limited₹1.01 L Cr₹1,049.369.89.3913.4%0.32+19.0%-10.6%
Dr. Reddy's Laboratories Limited₹97,876.16 Cr₹1,18529.62.6011.4%0.21+3.2%-10.4%
Manipal Health Enterprises Limited₹97,364.22 Cr₹738.95146.611.567.8%1.53+18.0%
DECIPHER LABS LIMITED₹6.04 Cr₹5.70.29-14.9%0.02-37.8%-46.0%

Ranked by market cap within Healthcare, same metrics as the Fundamentals screener. Click a column to sort.

Documents

Official documents linked from their sources — offer documents as filed with SEBI (sebi.gov.in), annual reports and earnings-call transcripts as published on BSE (bseindia.com) and NSE (nseindia.com). Links open the source's own hosting; nothing is re-hosted here.

No stock news captured yet.